Ufonia
PrivateLast Round
Grant
Nov 6, 2026
Total Funding Raised
$2.71M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Ufonia operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a VC Round in August 2022.
Ufonia is a healthtech company that has developed an AI-driven voice technology designed to automate routine patient healthcare interactions through phone calls.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, NLP & Conversational AI, Patient Engagement, Telemedicine
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ufonia Comparables
Compare Ufonia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Limbic | 85% | |
| QuantumLoopAI | 80% | |
| Hyro | 77% |
For institutional investors. Book with your work email.
Ufonia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2026 | ||||
| VC Round | Aug 25, 2022 | ||||
| Grant | Jan 26, 2022 | ||||
| Angel | Oct 2, 2020 | ||||
| Grant | Sep 8, 2020 | ||||
Grant | Apr 3, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ufonia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| SBRI Healthcare | Grant |
| NHSX | Grant |
| UKRI Innovate UK | Grant |
| Wavemaker Three-Sixty Health | VC Round |
| Innovate UK | Grant |
| Science and Technology Facilities Council | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 7, 2026
NHS is trialing AI phone assistant for chronic illness patients.
- Nov 7, 2026
Collaborating with University of York and Newcastle University on virtual assistant development.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withNov 9, 2026
Ufonia Ltd. partners with n Cl on a clinical AI trial that uses AI calls alongside, rather than instead of, patients’ regular NHS care, with involvement from the University of York and funding from Innovate UK.
- is_developingNov 7, 2026
Ufonia Ltd. is developing Dora Care, a generative-AI telephone assistant that conducts natural spoken calls to monitor patients with osteoporosis in a two-year NHS trial in the United Kingdom, in partnership with researchers at the University of York and Newcastle University.
- partners_withNov 7, 2026
Ufonia Ltd. partners with University of York on a two-year Innovate UK-funded project assessing whether AI-led consultations safely support clinicians and fracture liaison services monitoring people with osteoporosis in United Kingdom on Nov 9th '26.
For institutional investors. Book with your work email.
Ufonia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ufonia's valuation, stock price, and market status.
Is Ufonia a public or private company?
Ufonia is a private company.
What is the current stock price of Ufonia?
Ufonia is a private company, so its shares have no public market price. Caplight tracks Ufonia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ufonia worth (valuation)?
Valuation information for Ufonia is not publicly available.
Can I buy Ufonia stock?
Ufonia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ufonia's last funding round?
Ufonia's most recent funding round was Grant on November 6, 2026.
Who are the main investors in Ufonia?
Key investors in Ufonia include Innovate UK, SBRI Healthcare, NHSX, UKRI Innovate UK, Wavemaker Three-Sixty Health.
Will Ufonia IPO soon?
No public IPO plans have been announced for Ufonia.
How can I track Ufonia secondary market activity?
Caplight tracks bids, offers, and trades in Ufonia's shares on secondary markets.